Yale School of Medicine

GLP-1 drugs: clinical trends, safety, and market shifts

291 clusters · 1104 sources · last updated about 14 hours ago

Latest: Novo Nordisk faces lawsuits over Ozempic and NAION risks

Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. Research suggests secondary benefits, including a 21% lower risk of fragility fr

Advances in longevity science and biological aging research

25 clusters · 82 sources · last updated about 19 hours ago

Latest: Dietary patterns linked to slower epigenetic aging

Research into biological aging continues to evolve, integrating biotechnological interventions with genetic and lifestyle studies. Current investigations focus on the accumulation of genetic mutations, chromosomal degrad

Expanded therapeutic research and management of GLP-1 drugs

25 clusters · 130 sources · last updated 2 days ago

Latest: Semaglutide study reveals long-term effects on caloric intake

Medical research continues to expand the therapeutic potential of GLP-1 receptor agonists like semaglutide and tirzepatide, linking them to mental health, respiratory, and cardiovascular benefits. Recent data suggests se

Clinical trials for pediatric and adolescent obesity

2 clusters · 6 sources · last updated 5 days ago

Latest: Ecknoglutide shows significant weight loss in adolescent obesity trials

Clinical trials for obesity treatments targeting children and adolescents have reported positive results for new medications. In September 2026, Novo Nordisk announced that its phase 3 STEP Young trial for semaglutide m

Clinical applications and access of CAR-T cell therapy

16 clusters · 59 sources · last updated 5 days ago

Latest: Oncology researchers expand immunotherapy research for CLL and HIV-associated lymphoma

CAR-T cell therapy continues to expand its clinical utility across oncology and autoimmune diseases. In oncology, the therapy is transforming treatment for aggressive lymphomas and resistant blood cancers. A significant

STAREE trial and evolving cholesterol treatments

9 clusters · 20 sources · last updated 6 days ago

Latest: STAREE study: Atorvastatin reduces major heart events in elderly by 30%

The STAREE trial, a large-scale clinical study involving nearly 10,000 participants from Australian general practices, has demonstrated that daily atorvastatin significantly reduces the risk of major cardiovascular event

Cancer immunotherapy research and access challenges

4 clusters · 13 sources · last updated 12 days ago

Latest: Immunotherapy advances target cancer and autoimmune diseases

Recent research into cancer immunotherapy has focused on understanding side effects, treatment timing, and the influence of other vaccines on patient outcomes. Initial studies identified that inflammatory arthritis caus

Knee osteoarthritis treatment and monitoring advancements

2 clusters · 5 sources · last updated 26 days ago

Latest: Advancements in knee osteoarthritis treatment and mobility tracking

Medical advancements in the treatment and monitoring of knee osteoarthritis have expanded to include minimally invasive procedures, biomaterial implants, and wearable technology. Researchers at Charité – Universitätsmed

Caloric restriction and age-related inflammation research

2 clusters · 5 sources · last updated 29 days ago

Latest: Yale researchers identify mechanism for calorie restriction to reduce inflammation

Research indicates that moderate caloric restriction may reduce chronic inflammation associated with aging. Studies involving participants who reduced energy intake by approximately 14 percent over two years showed lower